ethyl 4-isothiocyanatobutanoate has been researched along with Fibrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chalupa, I; Horakova, K; Horvathova, M; Kuricova, M; Liskova, A; Seemannovaa, Z; Sovcikova, A; Tulinska, J | 1 |
| Floch, L; Horáková, K; Jantová, S; Novotná, L; Stred'anský, M | 1 |
2 other study(ies) available for ethyl 4-isothiocyanatobutanoate and Fibrosarcoma
| Article | Year |
|---|---|
Immunotoxic and cancerostatic effects of ethyl-4-isothiocyanatobutanoate in female Lewis rats with implanted fibrosarcoma.
Topics: Animals; Antineoplastic Agents; B-Lymphocytes; Body Weight; Butyrates; Dose-Response Relationship, Drug; Female; Fibrosarcoma; Isothiocyanates; Leukocytes; Neoplasms, Experimental; Organ Size; Phagocytosis; Rats; Rats, Inbred Lew; Spleen; T-Lymphocytes | 2002 |
Ethyl 4-isothiocyanatobutanoate--antiproliferative activity in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Butyrates; Cell Division; DNA, Neoplasm; Fibrosarcoma; HeLa Cells; Humans; Isothiocyanates; Lethal Dose 50; Neoplasm Proteins; Neoplasm Transplantation; Rats; Rats, Sprague-Dawley; RNA, Neoplasm; Thiocyanates | 1993 |